LIFEHOUSE GYNAECOLOGICAL ONCOLOGY GROUP...questionnaire (GCNQ). eposter presentation at the...

ANNUALREPORT

LIFEHOUSEGYNAECOLOGICALONCOLOGYGROUP

2016

Preparedby

ProfessorJonathanCarter

MBBS,DipRACOG,FACS,FRANZCOG,MS,MD,CGOProfessorGynaecologicalOncology,TheUniversityofSydney

Head,LifehouseGynaecologicalOncologyGroup

ProvidingExcellencein

Teaching,Research,Education,PatientCare,Administration

3

TableofContentsIntroduction......................................................................................................................4

Highlights..........................................................................................................................5

SummaryStatistics............................................................................................................6OverallActivity...........................................................................................................................6NewCancers..............................................................................................................................6InPatient...................................................................................................................................6OutPatient................................................................................................................................6MajorSurgery............................................................................................................................6MinorSurgery............................................................................................................................7LOS.............................................................................................................................................7KPI’s...........................................................................................................................................7AE’sGrade3&4.........................................................................................................................7MeetingAttendance..................................................................................................................7

Publications.......................................................................................................................8

InternationalPresentations.............................................................................................10

BookChapters.................................................................................................................10

NationalPresentations....................................................................................................10

StatePresentations.........................................................................................................12

LocalandRegionalPresentations....................................................................................12

Abstracts.........................................................................................................................14

AdministrativeResponsibilities&Committees................................................................14

PhD&ResearchSupervision............................................................................................15

Grant,Trial&ManuscriptReviews2016..........................................................................16

RANZCOGActivities.........................................................................................................18

EthicsSubmissions..........................................................................................................18

GrantsSubmissions.........................................................................................................19

MembershipsinProfessionalOrganizations....................................................................19

EditorialCommittee........................................................................................................19

CourseOrganizationorInstruction..................................................................................19

InvitedLectureship,Guest,ProgramChair,GrandRoundsPresentations.........................20

Teaching,MedicalStudent&UniversityActivities...........................................................20

Courses&ConferencesAttended....................................................................................21

Fundraising,Media..........................................................................................................22

Research.........................................................................................................................23

4

IntroductionIt is an honor and privilege, as Head of the LifehouseGynaecologic Oncology Group, to present the 2016AnnualReportfortheLifehouseGynaecologicOncologyGroup.This year concludes our 3rd yearwithin Lifehouse.MyDepartmentcontinuestodevelopandexpand.Ourseniormedical staff comprise myself, A/Prof Selvan Pather,A/ProfSamSaidiandA/ProfTrevorTejada-Berges.OurseniornursesareShannonPhilp,ourNursePractitionerand Belinda Zielony our Clinical Nurse Consultant. Dr.Luciano Rangel from Brazil and Dr. Pearl Tong from

SingaporeareourFellowsandDr.KingManWanourLifehouseGynaecologicOncologyRegistrar. Stephen Cotterell remains our data manager and programmer for ourDatabaseandPatientManagementSystem.OureverfaithfulandreliableChristineYoungisourPatientNavigator.

5

Highlights1. ProfCarterwasinvitedtowriteanEditorialforMedicalJournalofAustraliaon

theRenewaloftheNationalCervicalCancerScreeningProgram,whichsubsequentlyledtomediainterviewsonChannel9andABCRadioNational(http://www.abc.net.au/radionational/programs/healthreport/cervical-cancer-screening/7938108#transcript)

2. A/ProfMarceloNascimentowasappointedtotheUnitandtothenewlyformedAdvancedGISurgicalProgramatRPAH.

3. A/ProfPatherwasamemberoftheRenewalPanelfortheNationalCervicalScreeningProgramme.

4. A/ProfSaidipassedhiswrittenexaminationoftheCGOexaminationon19thJuly2016andwassubsequentlyawardedfullCGOcertificationon29thNovember2016.

5. A/ProfSaidicommencedRapidAccessHysteroscopyservice.6. A/ProfTejada-BergeswasappointedtotheEducationalCommitteeofthe

InternationalGynecologicCancerSociety(IGCS).7. A/ProfTejada-Bergesperformedthe100throboticsurgeryatChrisO’Brien

Lifehouseon2ndNovember2016.8. A/ProfTejada-BergespassedtheoralcomponentofCGOExaminationon20th

November2016.9. BelindaZielonywasappointedtoCancerNursesSocietyofAustralia(CNSA)

GynaecologicalSpecialistPracticeNetworkCommittee.

6

SummaryStatisticsOverallActivityYear Inpatients Outpatients NewCancers2014 669 6162 2292015 749 6181 2242016 825 7214 252NewCancers

Carter Pather Saidi Tejada-Berges

Other Total

2014 50 70 45 61 3 2292015 48 64 61 48 3 2242016 60 68 56 60 8 252NewCancers(Breakdownbytumoursite)Year New

CancersCervix Corpus Uterine

SarcomaOvary SexCord

StromalGermCell

Vulva Vagina

2014 229 40(17%) 66(29%) 11(4.8%) 53(23%) 3(1.3%) 2(0.87%) 14(6.1%) 0(0%)2015 224 30(13%) 63(28%) 9(4%) 62(28%) 2(0.89%) 4(1.8%) 10(4.5%) 2(0.89%)2016 252 31(12%) 93(37%) 7(2.8%) 63(25%) 4(1.6%) 3(1.2%) 15(6%) 2(0.79%)

InPatient


Other Total

2014 205 202 109 153 0 6692015 177 226 149 197 0 7492016 181 233 192 206 13 825IncludesConsultsOutPatient


Other Total

2014 1493 1867 1203 1211 388 61622015 1414 1593 1444 1465 265 61812016 1362 1751 1846 1613 642 7214MajorSurgery


Other Total

2014 60 114 63 114 0 3512015 47 95 81 102 1 3262016 58 100 81 89 9 337

7

MinorSurgery


Other Total

2014 118 67 29 27 0 2412015 110 95 54 65 0 3242016 106 125 94 92 7 424LOS Carter Pather Saidi Tejada-

BergesOther Total

2014 2.84 2.74 2.12 3.66 - 2.842015 2.85 2.78 2.55 2.89 2.772016 3.22 2.97 2.2 2.84 2.81KPI’s Carter Pather Saidi Tejada-

BergesOther Total

2014 21 21 18 26 0 862015 13 15 15 19 0 622016 18 26 19 19 5 87AE’sGrade3&4


Other Total

2014 4 5 1 10 0 202015 4 3 4 2 0 132016 8 15 5 6 0 34MeetingAttendance


Other Total

2014MDTM&M

378

346

4110

4111

--

2015MDTM&M

418

367

409

379

--

2016MDTM&M

359

357

4010

3911

--

8

Publications

Carter1. BlainG,RichardsA,PatherS,CarterJ,SaidiS.Aretrospectiveobservational

studyfortheoutcomesofwomenpresentingtoacolposcopyclinicwithahighgradePapsmear-implicationsfora“seeandtreat”approachtomanagement.AustNZJObstetGynaecol2016;56:207-211.

2. WanKM,CarterJ,PhilpS.PredictorsofearlydischargeafteropengynaecologicalsurgeryinthesettingofanEnhancedRecoveryAfterSurgeryprotocol.JObstetGynecolResearch2016;42(10):1369-1374.

3. MittalP,Klingler-HoffmanM,ArentzG,WinderbaumL,LokmanNA,ZhangC,AndersonL,ScurryJ,LeungY,StewartC,CarterJ,KaurGOehlerM,Hoffmann.Lymphnodemetastasisofprimaryendometrialcancers:associatedproteinsrevealedbyMALDIimaging.Proteomics2016;16:1793-1801.

4. CarterJ,WanKM,PhilpS.Optimisingrecoveryaftersurgery.Predictorsofearlydischargeandhospitalreadmission.ANZJOG2016;56:489-495.

5. OvarianCancerAssociationConsortium,BreastCancerAssociationConsortium,andConsortiumofModifiersofBRCA1andBRCA2,HollestelleA,vanderBaanFH,BerchuckA,JohnattyS,AbenKK,AgnarssonBA,AittomäkiK,AlducciE,AndrulisIL,Anton-CulverH,AntonenkovaNN,AntoniouAC,ApicellaC,ArndtV,ArnoldN,ArunBK,ArverB,AshworthA,AustralianOvarianCancerStudyGroup,BagliettoL,BalleineR,BanderaEV,BarrowdaleD,BeanYT,BeckmannL,BeckmannMW,BenitezJ,BergerA,BergerR,BeuselinckB,BisognaM,BjorgeL,BlomqvistC,BogdanovaNV,BojesenA,BojesenSE,BollaMK,BonanniB,BrandJS,BrauchH,BreastCancerFamilyRegister,BrennerH,BrintonL,Brooks-WilsonA,BruinsmaF,BrunetJ,BrüningT,BudzilowskaA,BunkerCH,VALIDHTML,BurwinkelB,ButzowR,BuysSS,CaligoMA,CampbellI,CarterJetal.NoclinicalutilityofKRASvariantrs61764370forovarianorbreastcancer.GynecologicOncology2016;141,(2):386-401.

6. CarterJ.TherenewaloftheNationalCervicalScreeningProgram.Editorial.MJA2016;205(8):357-358.

7. CarterJ.HammondI,SmithM.Letter.MJA2016(InPress).8. RebbeckR,FriebelT,MitraN,FeiF,ChenS,AndrulisI,ApostolouP,ArnoldN,

ArunB,BarrowdaleD,BenitezJ,BergerR,BerthetP,BorgA,BuysS,CaldesT,CarterJetal.InheritanceofDeleteriousMutationsatBothBRCA1andBRCA2inanInternationalSampleof32,295Women.BreastCancerResearch2016(InPress).

9. MittalP,Klingler-HoffmannM,ArentzG,WinderbaumL,KaurG,AndersonL,ScurryJ.LeungY,StewartC,CarterJ,HoffmanP,OehlerM.AnnexinA2andalphaactinin4expressioncorrelateswithmetastaticpotentialofprimaryendometrialcancer.BiochimicaetBiophysicaActa2016(InPress).

10. FarrellR,DixonS,CarterJ,WebbPM.Lymphadenectomyinearly-stageintermediate/high-riskendometrioidendometrialcancer:clinicalcharacteristicsandoutcomesinanAustraliancohort.IntJGynCancer2016(InPress)

11. MortonR,AndersonL,CarterJ,PatherS,SaidiSA.IntraoperativeFrozenSectionofOvarianTumors:A6-YearReviewofPerformanceandPotentialPitfallsinanAustralianTertiaryReferralCenter.IntJGynecolCancer.2016Dec3.[Epubaheadofprint]

9

12. HayesS,JandaM,LeighC,WardLC,Reul-HircheH,CarterJ,QuinnM,SteeleML,CornishB,ObermairA.Lymphedemafollowinggynecologicalcancer:Resultsfromaprospective,longitudinalcohortstudy.TheLancetOncology.2016(Submitted).

Pather1. BlainG,RichardsA,PatherS,CarterJ,SaidiS.Aretrospectiveobservational

studyfortheoutcomesofwomenpresentingtoacolposcopyclinicwithahigh-gradePapsmear-Implicationsfora'seeandtreat'approachtomanagement.AustNZJObstetGynaecol.2016Apr;56(2):207-11

2. DavisG,AndersonL,PatherS.ExtramammaryPaget’sdiseasemimickinglocalizedmalignancyoncervicalcytology.DiagnCytopathol.2016Nov;44(11):931-934.

3. MortonR,AndersonL,CarterJ,PatherS,SaidiSA.IntraoperativeFrozenSectionofOvarianTumors:A6-YearReviewofPerformanceandPotentialPitfallsinanAustralianTertiaryReferralCenter.IntJGynecolCancer.2016Dec3.[Epubaheadofprint]

Saidi1. SaidiS.ConsidertheTwist.AustralianDoctor12thFeb2016p16.2. MortonR,AndersonL,CarterJ,PatherS,SaidiSA.IntraoperativeFrozenSection

ofOvarianTumors:A6-YearReviewofPerformanceandPotentialPitfallsinanAustralianTertiaryReferralCenter.IntJGynecolCancer.2016Dec3.[Epubaheadofprint]

Tejada-Berges1. Tejada-BergesT.BreastCancer:GeneticsandRiskAssessment.ClinObstet

Gynecol.2016Dec;59(4):673-687.

Philp1. PhilpS,Mellon,A,BarnettC,D’AbrewN,WhiteK.Theroadlesstravelled:

AustralianWomen’sexperienceswithvulvalcancer.EuropeanJournalofCancerCare2016;doi:10.1111/ecc.12465

2. CarterJ,PhilpS,WanK.Optimisingrecoveryaftersurgery:Predictorsofearlydischargeandhospitalreadmission.AustralianandNewZealandJournalofObstetricsandGynaecology2016;56(5):489-495.

3. WanKM,CarterJ,PhilpS.PredictorsofearlydischargeafteropengynaecologicalSurgeryinthesettingofanenhancedrecoveryaftersurgeryprotocol.JournalofObstetricsandGynaecologyResearch2016;42(10):1369-1374.doi:10.1111/jog.1304

4. PhilpS,BarnettC,D’AbrewN,WhiteK.Nurseconfidenceingynaecologicaloncologypracticeandtheevaluationofaprofessionaldevelopmentmodule.SubmittedtoContemporaryNurse

Other1. WanKM,CarterJ,PhilipS.Predictorsofearlydischargeafteropen

gynaecologicalsurgeryinthesettingofanEnhancedRecoveryAfterSurgeryprotocol.JObstetGynecolResearch2016;42(10):1369-1374.

2. CarterJ,WanKM,PhilpS.Optimisingrecoveryaftersurgery.Predictorsofearlydischargeandhospitalreadmission.ANZJOG2016;56:489-495

10

InternationalPresentations

Philp1. LopezAL,JuraskovaI,CostaD,HobbsK,RobertsonR,PhilpS,PhillipsE,Butow

P.Psychosocialneedsofwomenwithgynaecologicalcancer:Prevalenceandcorrelationidentifiedbyanewlydevelopedgynaecologicalcancerneedsquestionnaire(GCNQ).eposterpresentationattheMultinationalAssociationofSupportiveCareinCancer(MASCC)InternationalConference,Adelaide,22-24June,2016

BookChapters

Pather1. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervical

ScreeningProgramme.Clinicalquestion:Diagnosisofhigh-gradesquamousabnormalities.NHMRCinpress

2. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeGuidelines:Cervicalcancer/Screening/DiscussionHSIL—NHMRCinpress

3. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeClinicalquestion:Follow-upofhighgradesquamouslesionspost-treatment:cytologyandHPVtestingat12vsat12and24mo(bodyofevidence·screenliteratureupdates)—NHMRCinpress

4. BrandA,HammondI,PatherS,RoeskeL,WredeD,NationalCervicalScreeningProgramme.Screeninginimmune-deficientwomen.NHMRCinpress.

5. AndersonL,GarretA,HammondI,PatherS,NationalCervicalScreeningProgramme.Clinicalquestion:Managementoflow-gradecervicalsquamousabnormalitiesinHPV-positivewomen.NHMRCinpress

6. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeClinicalquestion:TestofCureaftertreatmentforHSIL(CIN23)(bodyofevidence·screenliteratureupdates).NHMRCinPress

7. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeClinicalquestion:Treatmentofhigh-gradesquamousabnormalities(bodyofevidence·screenliteratureupdates)—NHMRCinpress

8. AndersonL,HammondI,PatherS,WredeD,WrightH,Guidelines:Cervicalcancer/Screening/Managementofglandularabnormalities—NHMRCinPress.

9. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeGuidelines:Cervicalcancer/Screening/Managementhistologicallyconfirmedhigh-gradesquamousabnormalities.NHMRCinpress

NationalPresentations

Carter1. TongP,PatherS,LeeP,RomeP,CarterJ.Clearcellcarcinomaarisingfrom

previousCaesareansectionscar.PosterPresentationatthe2016ASGOAnnualScientificMeeting.Tasmania,19-21stMay2016

2. WanKM,CarterJ,PhilpS,"Predictorsofearlydischargeafteropengynecologicalsurgeryinthesettingofanenhancedrecoveryaftersurgeryprotocol."PosterpresentationASGOASMTasmania,19-21stMay2016

11

Pather1. TongP,PatherS,LeeP,RomeP,CarterJ.Clearcellcarcinomaarisingfrom


2. PatherS.Principlesofelectrosurgeryandlaser.ASCCPtreatmentcourseingynaecologicdysplasia.Lifehouse,SydneyAustralia.19thDecember2016.

3. PatherS.Techniqueoflaserandsafetyissues.ASCCPtreatmentcourseingynaecologicdysplasia.Lifehouse,SydneyAustralia.19thDecember2016.

Tejada-Berges1. Tejada-BergesT.CervicalDiseaseManagement:ExcisionalTechniques.ASCCP

CourseandUpdate.GoldCoast,QLD.2ndApril20162. Tejada-BergesT.ColposcopyintheYoungandOld.ASCCPCourseandUpdate.

GoldCoast,QLD.3rdApril2016.3. Tejada-BergesT.Vulvarintra-epithelialneoplasia(VIN)andanalintra-

epithelialneoplasia(AIN).ASCCPCourseandUpdate.GoldCoast,QLD.3rdApril2016.

4. Tejada-BergesT.ColposcopyintheYoungandOld.ASCCPCourseandUpdate.Darwin,NT.18thSeptember2016.

5. Tejada-BergesT.Vulvarintra-epithelialneoplasia(VIN)andanalintra-epithelialneoplasia(AIN).ASCCPCourseandUpdate.Darwin,NT.18thSeptember2016.

Philp1. LopezAL,JuraskovaI,CostaD,HobbsK,RoberstsonR,PhilpS,PhillipsE,Butow

P.Psychosocialneedsofwomenwithgynaecologicalcancer:Prevalenceandcorrelationidentifiedbyanewlydevelopedgynaecologicalcancerneedsquestionnaire(GCNQ).Oralpresentation,AustralianNewZealandGynaecologicalOncologyGroup(ANZGOG),ASM,13-16April,2016


Other1. TongP,PatherS,LeeP,RomeP,CarterJ.Clearcellcarcinomaarisingfrom



12

StatePresentations

Pather1. PatherS,GirgisA,ButowP.SelfCareforprofessionals.PanelDiscussion.

InnovationsinCancerTreatmentandCareConference.CancerCouncilofNSW.16September2016.TechnologyPark,Redfern.Sydney.

Other1. El-AchiV,MarshallD,WanKM,ChuaS,McGeeT,“Readmissionsforsurgicalsite

infectionsfollowingcaesareansection”2016RANZCOGNSW/QLDRegionalScientificMeeting,11-12thJune2016

LocalandRegionalPresentations

Carter1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing

treatmentforCIN2/3inanAustralianpopulation.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.

2. TongP,PatherS,LeeP,RomeP,CarterJ.ClearcellcarcinomaarisingfromapreviousCaesareansectionscar.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.

3. WanKM,Tejada-BergesT,PatherS,CarterJ,SaidiS.TheuseofaModifiedCapriniScoreingynaecologicaloncologypatients.Oralpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.

Pather1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing




Saidi1. SaidiS.RapidAccessHysteroscopy–a‘OneStop’Shop.LifehouseGP

educationalevent.1stSept20162. SaidiS.ASCCPtrainingcourse.TechniqueofLEEPandsafetyaspects.17th

November20163. SaidiS.ImaginginOvarianCancer.AlfredImaging,CampsieNSW.8thApril2016

Tejada-Berges1. Tejada-BergesT.SexualhealthinWomenFollowingCancerTreatment.GP

Seminar.ChrisO’BrienLifehouse.16thMarch2016.2. Tejada-BergesT.CervicalCancerDiagnosis,StagingandSurgicalManagement.

ACIGynaecologicalOncologyNurses&AlliedHealthGroup(GONG)SeminarDay,RPAH.3rdJune2016.

13

3. Tejada-BergesT.HeyDoc,Ihearthere’sanewscreeningtestforovariancancer?GPSeminar.ChrisO’BrienLifehouse.1stSeptember2016.

4. Tejada-BergesT.RANZCOGReviewLecture:GynaecologicOncologyReview.ConcordHospital.13thMarch2016.

5. Tejada-BergesT.RANZCOGReviewLecture:GynaecologicOncologyReview.ConcordHospital.14thAugust2016.

Other1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing



14


Abstracts

Carter1. CarterJ.AdvancesinGynaecologicalCancerScreening.HPVandVaccination.

ChrisO’BrienLifehouse.1stSeptember20162. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing




Pather1. TongP,PatherS,CarterJ.Malignanttransformationinendometriosisinthe

anteriorabdominalwall.ASGOPeppersCradleMountainLodge,Tasmania18-21May2016.

2. RangelL,TejadaBergesT,PatherS,CarterJ,SaidiS.OutcomesfollowingtreatmentofCIN2/3inanAustralianpopulation.LifehouseresearchsymposiumLifehouse,Sydney,Australia.14thOctober2016,

Other1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing




AdministrativeResponsibilities&Committees

Carter1. CarterJ.CommitteeMemberLifehouseClinicalLeadershipCommittee.2. CarterJ.ChairmanLifehouseMDACCommittee.3. CarterJ.ChairmanLifehouseTheatreAdvisoryCommittee.4. CarterJ.CommitteeMemberScientificAdvisoryPanel.TheAustralian

GynaecologicalCancerFoundation.5. CarterJ.CommitteeMemberScientificAdvisoryPanel.CompassTrial.6. CarterJ.CommitteeMemberSLHDAdvancedGISurgicalProgramSteering

Committee.

15

7. CarterJ.CommitteeMemberUro-OncologyInterviews.5thJanuary20168. CarterJ.CommitteeMemberHeadDepartmentBreastService1st&3rdMarch

2016

Pather1. PatherS.MemberoftheguidelinescommitteefortheNationalCervical

ScreeningProgramme.2. PatherS.MemberoftheMorbidityandMortalityCommitteeLifehouse.3. PatherS.CGOExaminationCommittee,RANZCOG4. PatherS.SteeringCommitteeOptimisingcervicalcancerpreventionamongst

AboriginalwomeninruralandremoteNewSouthWales5. PatherS.GynaecologicalOncologyModelScopeofClinicalPracticeCommittee,

20166. PatherS.ExecutiveMemberofASCCP

Tejada-Berges1. Tejada-BergesT.Co-optedMemberofAustralianSocietyofColposcopyand

CervicalPathology(ASCCP)CommitteeofManagement.Feb2016.2. Tejada-BergesT.EducationalCommitteeofInternationalGynecologicCancer

Society(IGCS).August2016.3. Tejada-BergesT.LifehouseRoboticSteeringCommittee.4. Tejada-BergesT.LifehouseRepresentativetoSLHDSurgicalRoboticsProgram

SteeringCommittee

Philp1. PhilpS.NSWACIGynaecologicalOncologyNursesGroup(GONG)Executive

Committee2. PhilpS.CNSA,GynaecologicalOncologySpecialistPracticeNetwork(GYNSPN)3. PhilpS.CNSANPSpecialistPracticeNetwork(NPSPN)4. PhilpS.CNSA,GYNSPN,2016Pre-Congressworkshopcommittee5. PhilpS.AdvisoryTeam,PreceptorshipofvisitingHongKongCancerNurses,

Lifehouse,October-November2016

Zielony1. ZielonyB.NSWACIGynaecologicalOncologyNurses&AlliedHealthGroup

(GONG)ExecutiveCommittee2. ZielonyB.CancerNursesSocietyofAustralia(CNSA)GynaecologicalSpecialist

PracticeNetworkCommitteeMember

PhD&ResearchSupervision

Carter1. CarterJ.Theroleofnaturaltreatmentintheregressionofearlycervical

dysplasiacausedbyhighriskHPV.Asystematicreviewoftheevidencefortheeffectivenessofnaturaltherapies(Carotenoids/micronutrients)intheregressionofcervicaldysplasiaandhighriskHPV.PhDSupervisionDr.PauletteMaroun.UniversityofTechnologySydney.2016

Pather1. PatherS.DrUHerbst.CIN2inanHPVnegativepopulation

16

2. PatherS.PearlTong.Pyometria,Acasereport3. PatherS.PearlTong.ManagementofStage2endometrialcancer4. PatherS.ReviewoftheThesisfulfillingtherequirementsfortheCGO–

Radiotherapyforisolatednodalrecurrenceingynaecologiccancer.11/2016

Saidi1. SaidiS.EskaroosM.AcceptabilityofoutpatientvsinpatientLEEPbiopsy.2. SaidiS.FeddersenJ.BleedingpatternsfollowingLEEPbiopsy,riskfactorsand

outcomes.3. SaidiS.GreyM.eQOLmeasurementtoolingynaecologicalcancerfollow-up4. SaidiS.LeighNicholson.TheRoleofalpha-parvininendometrialcancer.5. SaidiS.LucianoRangel.OutcomesfollowingtreatmentofCIN2/3

Philp1. PhilpS.AssociateSupervisorforDoctorofPhilosophyCandidate:Testingthe

feasibilityofabriefnurse-ledlifestyleinterventionforwomenwithtype1endometrialcancer,SchoolofNursing,TheUniversityofSydney-Thesissubmitted

Grant,Trial&ManuscriptReviews2016

Carter1. CarterJ.Manuscriptreview.Prognosticsignificanceoffluorodeoxyglucose

positronemissiontomographymaximumstandardizeduptakevalueinstageIovarianclearcellcarcinoma:aretrospectiveobservationalstudy.HaruhisaKonishi,KazuhiroTakehara,ShinichiOkame,MasaakiKomatsu,YukoShiroyama,TakashiYokoyama,YoshifumiSugawara.OpenJournalofObstetricsandGynecology30thJanuary2016

2. CarterJ.Manuscriptreview.ManuscriptNumberIGC-D-16-00020.Improveddetectionrateofovariancancerusingatwo-steptriagemodeloftheRiskofMalignancyIndex(RMI)andexpertsonographyinanoutpatientscreeningsetting.6thFebruary2016

3. CarterJ.Manuscriptreview.ManuscriptNumberIJG-D-16-00121.Theprognosisofhighriskearlystagecervicalcancerpatientswhodidnotreceivepostoperativeconcurrentchemoradiotherapy.9thFebruary2016

4. CarterJ.Manuscriptreview.ManuscriptNumbermja15.01404.Qualityofsalpingoophorectomyforovariancancerprevention:stillroomforimprovement.16thFebruary2016

5. CarterJ.Manuscriptreview.ManuscriptNumberW16-0301.Menstrualpatternafterabdominalradicaltrachelectomy.AmJObstetGynecol.WuXetal.28thFebruary2016

6. CarterJ.Manuscriptreview.ManuscriptNumberANZJOG-2016-0036.Theroleofsurgicalstaginginthetreatmentofapparentearly-stagemalignantovariangermcelltumours.AustNZJObstetGynaecol.13thMarch2016

7. CarterJ.ManuscriptReview.ANZJOG-2016-0054.Outcomesofgeneticparticipationingynaecological-oncologymultidisciplinarymeetings:changingpatternsofreferralandoutcomes.27thMarch2016

17

8. CarterJ.ManuscriptReview.IJG-D-16-00348.PredictivevalueoftheserumHE4andCA125concentrationsforthelymphaticmetastasisofendometrialcancer.6thApril2016

9. CarterJ.ManuscriptReview.“Cervicalcancerinwomenunder25yearsofageinQueensland,Australia:Isthenewnationalcervicalscreeningprogramsafeforyoungerwomen?”MJA16.00329.13thApril2016

10. CarterJ.ManuscriptReview.ManuscriptNumberANZJOG-2016-0335.Efficacyofintermittentpneumaticcompressionforvenousthromboembolismandprophylaxisinpatientsundergoinggynecologicsurgery:asystematicreviewandmetaanalysis.ANZJOG18thNovember2016

11. CarterJ.ManuscriptReview.ManuscriptNumberE16-1116.Theimpactofadjuvanthysterectomyonprognosisinpatientswithlocallyadvancedcervicalcancertreatedwithdefinitiveconcurrentchemoradiotherapy:Ameta-analysis.AmJObstetGynecol24thNovember2016

Pather1. PatherS.UnderstandingVulvarandVaginalCancers.CancerCouncilofNSW

21stSeptember2016.2. PatherS.IDCJOG-2016-0347Relationshipbetweenobesityand

symptomatologyinwomenundergoinghysterectomyforprolapse.JournalofObstetricsandGynaecology.2ndOctober2016

3. PatherS.ANZJOG-2016-0182entitled"Prognosticimpactofselectivelymphadenectomybasedonpre-operativecharacteristicsinpatientswithendometrialcancer:acase-controlstudy.August2016

4. PatherS.ANZJOG-2016-0326entitled"InitialobservationofCIN2doesnotappeartoreducequalityoflifeinwomenunder25yearsofage.December2016.

Saidi1. SaidiS.InternationalJournalofGynaecologicalCancer.IJGCIGC-D-16-00076.

22ndFebruary2016.2. SaidiS.Editor.CancerCouncil“UnderstandingCanceroftheUterus”official

patientpamphlet.20thDec2016.

Tejada-Berges1. Tejada-BergesT.NationalBreastCancerFoundation,Grantreviewer:2017

InfrastructureGrants.September2016.2. Tejada-BergesT.SupportiveCareinCancer,Manuscriptreview:Manuscript

No:JSCC-D-16-00642.September2016.3. Tejada-BergesT.IGCSJournal,manuscriptreview:ManuscriptIGC-D-16-

00557.November2016.

Philp1. PhilpS.Abstractreview:InternationalConferenceonCancerNursing(ICCN),

HongKong,China,September20162. PhilpS.AustralianJournalofCancerNursing,Manuscriptreview,ID2016-33. PhilpS.EuropeanJournalofCancerCare,Manuscriptreview,ECC-2015-

0190.R24. PhilpS.EuropeanJournalofCancerCare,Manuscriptreview,ECC-2015-

0190.R15. PhilpS.CancerCouncilNSW,UnderstandingOvarianCancerbooklet,June2016

18

Other1. WanKM.PeerreviewerforTrialsJournal,ProtocolTRLS-D-16-00265R121st

July20162. WanKM.PeerreviewerforTrialsJournal,ProtocolTRLS-D-16-00265R23rd

October2016

RANZCOGActivities

Pather1. PatherS.CollegeExaminerfortheCGOSubspecialityexaminations:College

HouseNovember2016

Saidi1. SaidiS.RANZCOGbasicsurgicalskillsworkshop.Trainer.20th-21stFeb20162. SaidiS.RANZCOGpart2revisioncoursepresentation.VulvalCancer.25thOct

20163. SaidiS.RANZCOGpart2revisioncoursepresentation.CervicalCancer.25thOct

2016

Tejada-Berges1. Tejada-BergesT.MRANZCOGRevisionCourse:SurgicalPelvicAnatomy,Rydges

Hotel,NorthSydney,24thOctober2016.2. Tejada-BergesT.MRANZCOGRevisionCourse:GestationalTrophoblastic

DiseaseReview,RydgesHotel,NorthSydney,25thOctober2016.3. Tejada-BergesT.MRANZCOGRevisionCourse:OvarianCancerManagement

Review,RydgesHotel,NorthSydney,25thOctober2016.

Other1. WanKM.AcceptedforGynaecologicalOncology(CGO)Trainingprogramfor

2017,SubspecialtiesTrainingProgram,RANZCOG2. WanKM.RANZCOGBasicSurgicalSkillsCourseFacilitator,KollingInstitute-

RoyalNorthShoreHospital,21stFebruary2016

EthicsSubmissions

Pather1. PatherS.Pelvicsepsisfollowingahysteroscopyforpyometria.Acasereport.2. HerbstU,WongE,PatherS.ProtocolNoX15-0389&HREC/15/RPAH/532-

“ImmunohistochemistryforHPVtestingonarchivedtissueinwomenwithbiopsyprovenhighgradecervicaldysplasiaandnegativeHPVtesting”

3. TongP,PatherS.ProtocolNoX16-0476&LNR/16/RPAH/680-“ThedemographicsandoutcomesofwomenwithStageIIendometrialcarcinomamanagedinAustralia(2005-2007)

19

GrantsSubmissions

Carter1. ObermairA,QuinnM,BrennanD,ArmesJ,JandaM(CI),CarterJ(AI).Improving

thetreatmentforwomenwithearlystagecanceroftheuterus(feMMe).2016NHMRCProjectGrant

MembershipsinProfessionalOrganizations

Carter1. CarterJ.RoyalAustralianCollegeObstetriciansandGynaecologists.2. CarterJ.AustralianMedicalAssociation.3. CarterJ.AustralianSocietyGynaecologicalOncologists.4. CarterJ.AmericanCollegeofSurgeons.5. CarterJ.InternationalSocietyofGynecologicCancer.6. CarterJ.SocietyofGynecologicOncologists.Member.7. CarterJ.UniversityofSydneyAssociationofProfessors.

EditorialCommittee

Pather1. PatherS.AustinJournalofObstetricsandGynaecology

CourseOrganizationorInstruction

Pather1. PatherS.ASCCPtreatmentcourseinGynaecologicDysplasia.Lifehouse19

November2016

Philp1. PhilpS.LecturerandCourseCoordinator,CancerandHaematologyNursing,

SydneyNursingSchool,TheUniversityofSydney2. PhilpS.OrganisingCommittee.ACIGONG,“CervicalCancer”,RPAH,3June20163. PhilpS.OrganisingCommittee.ACIGONG,“EndometrialCancer”,RPAH,28April

2017

Zielony1. ZielonyB.OrganisingCommittee.ACIGynaecologicalOncologyNurses&Allied

HealthGroup(GONG)“CervicalCancer”RPAH.3rdJune2016

Other1. TongP.FacilitatoratASCCPLEEPWorkshop.Sydney19thNovember20162. WanKM.ASCCPLEEPWorkshopFacilitator,ChrisO’BrienLifehouse

19thNovember2016

20

InvitedLectureship,Guest,ProgramChair,GrandRoundsPresentations

Philp1. PhilpS.Chairofsession.ACIGONG,“CervicalCancer”,RPAH,3June2016

Tejada-Berges1. Tejada-BergesT.InvitedLecturesforAcademiaMedical0b/GynReview

Course.23-25June,2016.

Other1. WanK,TejadaBergesT,“Overviewofendometrialhyperplasiaanduterine

cancer”2016FRANZCOGRevisionCourse.RydgesHotel,NorthSydney.25thOctober2016

2. WanK,“ApproachtoPVBleedingforInterns”RoyalPrinceAlfredHospital.9thNovember2016

Teaching,MedicalStudent&UniversityActivities

Carter1. CarterJ.Lecture.HPV,VaccinationandScreening.AbercrombieBusinessSchool

LectureTheatre,UniversityofSydney.24rdOctober2016

Pather1. PatherS.Co-organizer:CervicalCancerPathology,UniversityofSydney,21nd

October,2016.2. PatherS.Colposcopyandtreatmentofdysplasia.Scorpioyear2medicine.

ClinicalTrainingUnit,RPAH.21stOctober20163. PatherS.StudentLecturesMed4PostmenopausalbleedingandCervical

dysplasia/cancer15/03/16;17/05/16;19/07/16;04/10/16

Saidi1. SaidiS.UniversityofSydneyMedicalSchool.SCORPIOteachingsession.Smears

andcytology.21stOct20162. SaidiS.UniversityofSydneyMedicalSchool.Part2OSCEexaminer.1stNov

20163. SaidiS.UniversityofSydneyMedicalSchool.Stage2PPDinterviews.6th-14th

Nov2016.

Philp1. PhilpS.LecturerandCourseCoordinator,CancerandHaematologyNursing,

SydneyNursingSchool,TheUniversityofSydney2. PhilpS.ExpertPeerReviewPanelMember.MasterofNursing(NP)FinalViva,

October2016

TejadaBerges1. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.17th

March2016.

21

2. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.19thMay2016.

3. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.21stJuly2016.

4. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.6thOctober2016.

5. Tejada-BergesT.CervixCancerScorpioTutorial:MacroscopicFeaturesandClinicalStagingofCervixCancer.21stOctober2016.

Other1. RangelL,WanK,TongP,PatherS.Colposcopyandtreatmentofdysplasia.

MedicalstudentsScorpioteachingactivity.RoyalPrinceAlfredHospital,UniversityofSydney,Sydney,NSW,Australia,21October2016.

Courses&ConferencesAttended

Philp1. PhilpS.19thAnnualCNSAWinterCongress,Cairns,May20162. PhilpS.ACIGONG,“CervicalCancer”,RPAH,3June20163. PhilpS.NursingStrategyDayWorkshop,Lifehouse,July2016

TejadaBerges1. Tejada-BergesT.BRCA:ChallengesandOpportunities,SixthInternational

SymposiumonHereditaryBreastandOvarianCancer.CentreMont-Royal,Montréal,Canada.10-13May,2016.

Other1. TongP.AttendanceASGOASMConference.CradleMountainTasmania,19-21st

May20162. WanKM.AttendanceASGOASMConference.CradleMountainTasmania,19-

21stMay2016

22

Fundraising,Media

Carter1. CarterJ.Channel9News.TherenewaloftheNationalCervicalScreening

Program.17thOctober2016.http://www.mylifehouse.org.au/11189-2/

2. CarterJ.ABCRN.TherenewaloftheNationalCervicalScreeningProgram.17thOctober2016.http://www.abc.net.au/radionational/programs/healthreport/cervical-cancer-screening/7938108#transcript

Saidi1. SaidiS.Chairman’slunchpresentation.Supra-radicalsurgeryinOvarianCancer

–thecaseforaspecialisedcentre.ChrisO’BrienLifehouse.18thMarch2016

Tejada-Berges1. Tejada-BergesT.“BreakfastofChampions”.AustraliaSchoolFundraiserfor

ChrisO’BrienLifehouse.6thMay2016.

23

ResearchLHReference StudyTitle ProtocolLH13.003 PARAGON(ANZGOG0903)PhaseIIstudyof

aromataseinhibitorsinwomenwithpotentiallyhormoneresponsiverecurrent/metastaticgynaecologicalneoplasms

ANZGOG0903

LH13.036 APhaseIIIStudytoEvaluatetheEfficacyandSafetyofPazopanibMonotherapyVersusPlaceboinWomenWhoHaveNotProgressedafterFirstLineChemotherapyforEpithelialOvarian,FallopianTube,orPrimaryPeritonealCancer(OVAR16)

AGO-OVER16/VEG11065

5

LH13.039 ClinicalStudyNo.1199.15Multicenter,randomised,double-blindphaseIIItrialtoinvestigatetheefficacyandsafetyofBIBF1120incombinationwithcarboplatinandpaclitaxelcomparedtoplacebopluscarboplatinandpaclitaxelinpatientswithadvancedovariancancer(OVAR12)

AGO-OVER16/VEG11065

5

LH13.055 IBCSG24-02/BIG2-02:APhaseIIItrialevaluatingtheroleofovarianfunctionsuppressionandtheroleofexemestaneasadjuvanttherapiesforpremenopausalwomenwithendocrineresponsivebreastcancer(SOFT)

IBCSG24-02/BIG2-02

LH13.056 ANZGOG0902:APhaseIIItrialofadjuvantchemotherapyfollowingchemoradiationasprimarytreatmentforlocallyadvancedcervicalcancercomparedtochemoradiationalone(TheOUTBACKTrial)

ANZGOG0902

LH14.018 AninternationalphaseIIIrandomisedtrialofdose-fractionatedchemotherapycomparedtostandardthree-weeklychemotherapy,followingimmediateprimarysurgeryoraspartofdelayedprimarysurgery,forwomenwithnewlydiagnosedepithelialovarian,fallopiantubeorprimaryperitonealcancer-ICON8

Icon8

LH14.024 AGO-OVAR2.21/ENGOT-ov18:AProspectiverandomizedPhaseIIItrialofcarboplatin/gemcitabine/bevacizumabvs.carboplatin/pegylatedliposomaldoxorubicin/bevacizumabinpatientswithplatinum-sensitiverecurrentovariancancer(AnENGOT/GCIGTrial)(OVAR2.21)

AGO-OVAR2.21

24

LH14.029 EMR200066_012:PhaseIIRandomisedDoubleBlindPlaceboControlledTrialofCombinationofPimasertibwithSAR245409orofPimasertibwithSAR245409PlaceboinSubjectswithPreviouslyTreatedUnresectableLowGradeOvarianCancer

EMR200066_012

LH15.035 Impactofrisk-reducingbilateralsalpingo-oophorectomyonnon-canceroutcomesinyounghighriskwomen:Amulticentreprospectivestudy(WHAM)

WHAM

LH15.037 ClinicalauditofsinglesurgeonexperiencewithFastTrackSurgeryingynaecologicalpatients

Authorised

LH15.048 Theconservativemanagementofyoungwomen,uptoage25,withcervicalintraepithelialneoplasia(CIN)2(PRINCESS)

PRINCess

LH15.049 ANZGOG1301:APhaseIIRandomisedClinicalTrialofMirena±Metformin±WeightLossInterventioninPatientswithEarlyStageCanceroftheEndometrium(FEMME)

ANZGOG-1301

LH16.018 Genomicmechanismsunderlyinglong-termresponsetotreatmentinserousovariancancer:anAustralianOvarianCancerStudyProject(AOCS)

Authorised

LH16.022 ClinicalStudyNo.M13-694,APhase3Placebo-ControlledStudyofCarboplatin/PaclitaxelWithorWithoutConcurrentandContinuationMaintenanceVeliparib(PARPinhibitor)inParticipantswithPreviouslyUntreatedStagesIIIorIVHigh-GradeSerousEpithelialOvarian,FallopianTube,orPrimaryPeritonealCancer

M13-694

LH16.023 ImmunohistochemistyforHPVtestingonarchivedtissueinwomenwithbiopsyprovenhighgradecervicaldysplasiaandnegativeHPVtesting

LH16.025 UnderstandingEndofLifeDecisionMakinginCancer

LH16.027 IsPreoperativeCarbohydrateLoadingTolerableandBeneficialinGynaecologicOncologySurgery

CARBLOADING

LH16.028 TheRoleofAlpha-ParvininHumanEndometrialCancerCells

LH16.045 INOVATe-IndividualisedOvarianCancerTreatmentThroughIntegrationofGenomicPathologyintoMultidisciplinaryCare

LH16.047 AnauditofthedeliverabilityofCarboplatinandWeeklyPaclitaxelasAdjuvantTherapyforOvarianFallopiantubeandPrimaryPeritonealCancerPatients

LIFEHOUSE GYNAECOLOGICAL ONCOLOGY GROUP...questionnaire (GCNQ). eposter presentation at the...

Documents

Transcript of LIFEHOUSE GYNAECOLOGICAL ONCOLOGY GROUP...questionnaire (GCNQ). eposter presentation at the...